Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men
Open Access
- 10 March 2009
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 145 (1) , 121-127
Abstract
Summary: Studies on the relationship between fibrinolysis and arterial thrombosis have been conflicting. Previously, we demonstrated that hypofibrinolysis, as measured by a plasma‐based assay, increased the risk of venous thrombosis. The present study investigated increased clot lysis time (CLT) measured with the same assay as a risk factor for myocardial infarction in a case‐control study including 421 men with a first myocardial infarction and 642 controls below 70 years. CLT was strongly associated with body‐mass index, lipid levels, blood pressure and C‐reactive protein. Overall, risk of myocardial infarction was 1·4‐fold (95% confidence interval (CI) 1·0–1·9) increased for CLT in the fourth quartile (longest CLT) compared with the first quartile. After adjusting for cardiovascular risk factors this risk disappeared (OR 1·0, 95%CI 0·6–1·5). In men aged <50 years the association was pronounced (OR 3·2, 95%CI 1·5–6·7). After adjustment for cardiovascular risk factors the risk was nearly twofold increased (OR 1·8, 95%CI 0·7–4·8). In men aged ≥50 years, no clear association between CLT and risk of myocardial infarction was found. Our study suggests that hypofibrinolysis increases the risk of a first myocardial infarction in young men, although the causality of this association remains to be determined.Keywords
This publication has 34 references indexed in Scilit:
- Plasminogen activator inhibitor-1, adipose tissue and insulin resistanceCurrent Opinion in Lipidology, 2007
- Curiouser and curiouser: Recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological rolesClinical Biochemistry, 2007
- Altered Fibrin Architecture Is Associated With Hypofibrinolysis and Premature Coronary AtherothrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- PAI-1 and the Metabolic SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Weak and non-independent association between plasma TAFI antigen levels and the insulin resistance syndromeJournal of Thrombosis and Haemostasis, 2003
- C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial CellsCirculation, 2003
- High Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma Precede a First Acute Myocardial Infarction in Both Men and WomenCirculation, 1998
- Interaction of Coagulation Defects and Cardiovascular Risk FactorsCirculation, 1998
- Fibrinolytic activity and clotting factors in ischaemic heart disease in womenBMJ, 1996
- Relationships of blood pressure to fibrinolysis: influence of anthropometry, metabolic profile and behavioural variablesJournal Of Hypertension, 1995